Substance Use and the Novel Coronavirus Pandemic: A Conversation With The Experts

Robin Nelson, MD, is the Former PsychU Major Depressive Disorder Section Advisor, a psychiatrist at DGR Comprehensive Behavioral Health LLC in Wyomissing, PA, and an attending psychiatrist at the Caron Foundation Treatment Center in Wernersville, PA. Dr. Nelson received his MD from Duke University’s School of Medicine. He completed his residency in Duke University’s Psychiatric Residency Education Program. Dr. Nelson is board certified by the American Board of Psychiatry and Neurology.

Roueen Rafeyan, MD, is the Chief Medical Officer for Gateway Foundation Addiction Treatment Centers and an Assistant Professor of Psychiatry at the Feinberg School of Medicine, Northwestern University. Dr. Rafeyan was identified as the Top Psychiatrist in the Nation by Consumer Reports in 2007. He is also a Distinguished Fellow of the American Psychological Association (APA) and American Society of Addiction. Dr. Rafeyan earned his MD at Istanbul University in Turkey and completed his residency at the University of Illinois at Chicago.

Rachel Self, PhD, is a Senior Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc.

Mark Tacelosky, PharmD, is a Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc.